Infliximab: A Promising New Treatment Option for Ulcerated Necrobiosis Lipoidica

Publisher： Karger

E-ISSN： 1421-9832|206|2|180-181

ISSN： 1018-8665

Source： Dermatology, Vol.206, Iss.2, 2003-03, pp. : 180-181

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Necrobiosis Lipoidica Therapy with Biologicals: An Ulcerated Case Responding to Etanercept and a Review of the Literature

By  

Dermatology, Vol. 221, Iss. 2, 2010-06 ,pp. : 117-121

Karger

Access to resources Recommend Favorite

Necrobiosis Lipoidica: Early Diagnosis and Treatment with Tacrolimus

By  

Case Reports in Dermatology, Vol. 3, Iss. 1, 2011-04 ,pp. : 89-93

Karger

Access to resources Recommend Favorite

Intralesional Infliximab in Noninfectious Cutaneous Granulomas: Three Cases of Necrobiosis Lipoidica

By  

Dermatology, Vol. 222, Iss. 3, 2011-05 ,pp. : 212-216

Karger

Access to resources Recommend Favorite

Dermoscopy of Necrobiosis Lipoidica and Granuloma Annulare

By  

Dermatology, Vol. 226, Iss. 4, 2013-06 ,pp. : 319-323

Karger

Access to resources Recommend Favorite

Clearance of Necrobiosis lipoidica with Fumaric Acid Esters

By  

Dermatology, Vol. 207, Iss. 4, 2004-01 ,pp. : 422-424

Karger

Access to resources Recommend Favorite